Loading page…
Healthcare
United Therapeutics Corporation is assigned an AlphaScore of 75/100, resulting in a B+ grade and a Buy signal on October 11, 2026. Key data points highlight an exceptional gross margin of 87.92% and a net margin of 41.94%. A prominent strength is its stellar profitability, evidenced by the high net margin. A potential risk lies in its moderate revenue growth of 10.61%, alongside evidence limited regarding debt metrics.
Written 11/10/2026, 00:34:21 UTC · Snapshot 11/10/2026